Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Liabilities and Shareholders Equity (2016 - 2026)

Rockwell Medical filings provide 16 years of Liabilities and Shareholders Equity readings, the most recent being $57.1 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 3.48% to $57.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $221.2 million, a 0.53% increase, with the full-year FY2025 number at $57.1 million, down 3.48% from a year prior.
  • Liabilities and Shareholders Equity hit $57.1 million in Q4 2025 for Rockwell Medical, down from $57.5 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $69.4 million in Q1 2021 to a low of $37.4 million in Q1 2022.
  • Median Liabilities and Shareholders Equity over the past 5 years was $53.5 million (2024), compared with a mean of $53.1 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: plummeted 46.1% in 2022 and later soared 39.41% in 2024.
  • Rockwell Medical's Liabilities and Shareholders Equity stood at $48.6 million in 2021, then decreased by 3.99% to $46.6 million in 2022, then rose by 11.88% to $52.2 million in 2023, then grew by 13.48% to $59.2 million in 2024, then dropped by 3.48% to $57.1 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $57.1 million (Q4 2025), $57.5 million (Q3 2025), and $52.6 million (Q2 2025) per Business Quant data.